Description

Remdesivir is a broad-spectrum antiviral nucleotide analog prodrug. It is a critical active pharmaceutical ingredient (API) primarily used in the research and development of antiviral therapeutics. This compound is essential for pharmaceutical manufacturers, research institutions, and CROs/CMOs engaged in developing treatments for serious viral infections. Our supply is characterized by high purity and reliable consistency to meet stringent R&D and production requirements.

Application

• Pharmaceutical API: Primary use as the active ingredient in the formulation of antiviral injectable drugs.
• Antiviral Research: A key reference standard and investigational compound in virology and infectious disease research.
• Drug Development: Used in preclinical and clinical studies for the development of novel antiviral therapies.
• Biochemical Studies: Employed to study the mechanism of action of viral RNA polymerase inhibition.
• GMP Manufacturing: Serves as the starting material or intermediate for the production of finished dosage forms under Good Manufacturing Practices.
• Reference Standard: Used in analytical laboratories for quality control and assay development via HPLC, LC-MS, etc.

Basic Information

Product Name	Remdesivir
CAS No.	1809249-37-3
Molecular Formula	C27H35N6O8P
Molecular Weight	602.59 g/mol
Synonyms	GS-5734; Veklury (Brand Name); Remdesivirum; (2S)-2-{(2R,3S,4R,5R)-[5-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxy-tetrahydro-furan-2-ylmethoxy]phenoxy-(S)-phosphorylamino}propionic acid 2-ethylbutyl ester; 9-[(2R,3R,4S,5R)-5-[[(S)-[[(S)-[[(2R,3S,4R,5R)-5-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy]-phenoxy-phosphoryl]amino]-propanoyl]amino]-3,4-dihydroxyoxolan-2-yl]-1-propan-2-ylpyrazolo[4,3-e]pyrimidine-3-carbonitrile
EINECS	Contact for details

Quality Control

Our Remdesivir is manufactured and controlled under a strict quality management system. Each batch undergoes comprehensive analytical testing, including HPLC for purity and assay, identification by spectroscopic methods, and stringent control of related substances and residual solvents. A detailed Certificate of Analysis (COA) is provided, confirming compliance with in-house specifications developed to meet the needs of pharmaceutical research and development. We support audits and can provide regulatory starting material documentation upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C) or as specified on the label. This material is hygroscopic (moisture-sensitive) and must be kept under inert conditions or in a desiccator after opening to maintain stability and potency. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single unknown impurity ≤ 0.5%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.